University of Navarra
If you are the contact person for this centre and you wish to make any changes, please contact us.
PhD in Pharmacy, Professor of Human Physiology at the University of Navarra, member of the CIBER Physiopathology of Obesity, Carlos III Health Institute and IDISNA (Navarra)
Researcher in the Gene Therapy and Regulation of Gene Expression Programme and Director of Innovation and Transfer at Cima University of Navarra
Professor of Immunology at the University of Navarra, CIMA researcher and co-director of the Department of Immunology and Immunotherapy at the Clínica Universidad de Navarra.
Senior Researcher of the Gene Therapy in Neurodegenerative Diseases Programme at the Centre for Applied Medical Research (CIMA), University of Navarra
Co-coordinator of the working group on Nutrition of the Spanish Society of Epidemiology (SEE), Professor of Preventive Medicine and Public Health at the University of Navarra, and member of CIBERobn
Professor of Preventive Medicine and Public Health at the University of Navarra and Adjunct Professor in the Department of Nutrition at the Harvard T.H. Chan School of Public Health (United States)
Professor and Head of the Preventive Medicine and Public Health Department
Professor of Journalism at the University of Navarra and coordinator of Iberifier (Iberian Digital Media Observatory).
Researcher of the Gene Therapy and Regulation of Gene Expression Programme at Cima (Centre for Applied Medical Research) University of Navarra
Researcher at the Laboratory of Experimental Ophthalmology, Faculty of Medicine, University of Navarra
A pioneering phase 1 clinical trial has tested a type of cancer immunotherapy. Researchers have modified patients' own T-lymphocyte receptors using the CRISPR tool to direct them against specific targets on their own tumours. The results are published in the journal Nature.
Research has tested a gene therapy method that targets overactive cells to treat epilepsy in mice. The results are published in the journal Science.
A study published in the journal Nature Medicine has tested a therapy based on CAR-T cells - T lymphocytes modified in the laboratory - to treat five patients with systemic lupus erythematosus who did not respond to conventional treatments. According to the study, the symptoms subsided in all of them and the improvement was maintained throughout the duration of the study.
A study published in the BMJ has found a link between overall ultra-processed food consumption and an increased risk of colorectal cancer in men. The association has not been seen in women.